1158 related articles for article (PubMed ID: 33689215)
21. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA
Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
Feili X; Wu S; Ye W; Tu J; Lou L
Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876
[TBL] [Abstract][Full Text] [Related]
23. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway.
Wang J; Chu ES; Chen HY; Man K; Go MY; Huang XR; Lan HY; Sung JJ; Yu J
Oncotarget; 2015 Mar; 6(9):7325-38. PubMed ID: 25356754
[TBL] [Abstract][Full Text] [Related]
24. miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN/PDGFR-β.
Chen X; Zhu S; Chen SY; Wang JN; Sun LJ; Tao SM; Li XF; Li HD; Sun YY; Xu CH; Suo XG; Ji ML; Huang C; Meng XM; Li J
Int Immunopharmacol; 2022 Sep; 110():109034. PubMed ID: 35834952
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of miR‑141 deactivates hepatic stellate cells by targeting the PTEN/AKT/mTOR pathway.
Liang H; Wang X; Si C; Duan Y; Chen B; Liang H; Yang D
Int J Mol Med; 2020 Jul; 46(1):406-414. PubMed ID: 32319536
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
Zheng J; Wang W; Yu F; Dong P; Chen B; Zhou MT
Cell Physiol Biochem; 2018; 46(1):82-92. PubMed ID: 29587268
[TBL] [Abstract][Full Text] [Related]
27. Prediction and verification of target of helenalin against hepatic stellate cell activation based on miR-200a-mediated PI3K/Akt and NF-κB pathways.
Fang B; Wen S; Li Y; Bai F; Wei Y; Xiong Y; Huang Q; Lin X
Int Immunopharmacol; 2021 Mar; 92():107208. PubMed ID: 33444919
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-146a-5p attenuates liver fibrosis by suppressing profibrogenic effects of TGFβ1 and lipopolysaccharide.
Zou Y; Cai Y; Lu D; Zhou Y; Yao Q; Zhang S
Cell Signal; 2017 Nov; 39():1-8. PubMed ID: 28739486
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-9 limits hepatic fibrosis by suppressing the activation and proliferation of hepatic stellate cells by directly targeting MRP1/ABCC1.
Sun J; Zhang H; Li L; Yu L; Fu L
Oncol Rep; 2017 Mar; 37(3):1698-1706. PubMed ID: 28098912
[TBL] [Abstract][Full Text] [Related]
30. miR-345-5p curbs hepatic stellate cell activation and liver fibrosis progression by suppressing hypoxia-inducible factor-1alpha expression.
Wang P; Fang Y; Qiu J; Zhou Y; Wang Z; Jiang C
Toxicol Lett; 2022 Nov; 370():42-52. PubMed ID: 36126797
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of miR-200b in biliary atresia patients accelerates proliferation and migration of hepatic stallate cells by activating PI3K/Akt signaling.
Xiao Y; Wang J; Chen Y; Zhou K; Wen J; Wang Y; Zhou Y; Pan W; Cai W
Cell Signal; 2014 May; 26(5):925-32. PubMed ID: 24412919
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol upregulates miR-455-5p to antagonize cisplatin ototoxicity via modulating the PTEN-PI3K-AKT axis.
Liu Y; Wu H; Zhang F; Yang J; He J
Biochem Cell Biol; 2021 Jun; 99(3):385-395. PubMed ID: 34077275
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
35. HOTAIR Epigenetically Modulates PTEN Expression via MicroRNA-29b: A Novel Mechanism in Regulation of Liver Fibrosis.
Yu F; Chen B; Dong P; Zheng J
Mol Ther; 2017 Jan; 25(1):205-217. PubMed ID: 28129115
[TBL] [Abstract][Full Text] [Related]
36. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis.
Son G; Hines IN; Lindquist J; Schrum LW; Rippe RA
Hepatology; 2009 Nov; 50(5):1512-23. PubMed ID: 19790269
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases.
Yang YL; Wang FS; Li SC; Tiao MM; Huang YH
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106784
[TBL] [Abstract][Full Text] [Related]
39. Ba-Qi-Rougan formula alleviates hepatic fibrosis by suppressing hepatic stellate cell activation via the MSMP/CCR2/PI3K pathway.
Xue Y; Zhu W; Qiao F; Yang Y; Qiu J; Zou C; Gao Y; Zhang X; Li M; Shang Z; Gao Y; Huang L
J Ethnopharmacol; 2024 Jul; 329():118169. PubMed ID: 38621463
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β stimulated HSCs in transgenic mice.
Li F; Ma N; Zhao R; Wu G; Zhang Y; Qiao Y; Han D; Xu Y; Xiang Y; Yan B; Jin J; Lv G; Wang L; Xu C; Gao X; Luo S
J Cell Mol Med; 2014 Jun; 18(6):966-74. PubMed ID: 24801603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
